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The  study of B  lymphocyte heterogeneity,  development,  and  function  has  been 
markedly  aided  by the  availability of mice with  the xidodetermined  immunologic 
defect (1).  These mice lack a population of late-developing B lymphocytes, which in 
normal mice is characterized by the presence of the membrane antigens Lyb-3, 5, and 
7. For convenience, we designate such cells as Lyb-5  + cells (2-4). 
Mice that have the xid-determined  defect are unresponsive to a  class of antigens 
represented by the pneumococcal polysaccharides and hapten derivatives of Ficoll, 
dextran, and levan (5-7). These antigens are referred to as type 2 thymus-independent 
(TI)  1 antigens.  Although  capable of stimulating responses in nu/nu  mice  (8),  recent 
work indicates that these antigens do indeed require some T  cell influences in order 
to stimulate in vitro responses (9; J.  R. Ketterman and K. Dodd, personal commu- 
nication). We will therefore refer to them as type 2 antigens, rather than as type 2 TI 
antigens,  the  designation  used  previously (10,  11).  Mice that  express the xid-deter- 
mined defect do respond relatively normally to type  1 TI antigens, antigens which 
have the property of being polyclonal B lymphocyte activators. Included in this group 
are the hapten derivatives of lipopolysaccharide (LPS), Brucella abortus,  and Nocardia 
water-soluble mitogen (11,  12). Recent studies indicate that these responses may also 
be T  cell regulated  (J. J. Mond, M. Howard, and W. E. Paul, unpublished observa- 
tions). Thus, we will designate these antigens simply as type 1 antigens. 
The immunologic functions defective in mice with the xid-determined  defect have 
generally been attributed to Lyb-5  + B cells, whereas responses obtained in these mice 
are a  function of Lyb-5- B cells. These conclusions have been supported in part by 
the study of functional properties of Lyb-5- cells from normal mice (13-15). 
To examine the possible influence that the thymus and/or T  lymphocytes might 
have in the development of the Lyb 5- set of B cells, we examined the immunologic 
reactivity of nu/nu  CBA/N  mice,  a  strain  that  both  expresses  the  xid-determined 
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defect  and  is  congenitally  athymic,  and  compared  their  reactivity  with  that  of 
CBA/N-nu/+  and  CBA/Ca-nu/nu  mice.  The latter,  although  genetically similar  to 
CBA/N has a  normal  (+)  allele at  the xid locus. This communication describes  the 
finding that  young CBA/N-nu/nu  mice (<8 wk of age)  show profound defects in B 
lymphocyte function not found in control mice that express only the xid- or nu/nu- 
determined  genetic defects. A  preliminary report of the properties  of these mice has 
already appeared  (16). 
Materials and Methods 
Mice.  CBA/N-+/nu  and nu/nu and CBA/Ca-+/nu  and nu/nu mice were supplied by the 
Small Animal Section of the Division of Research Services of the National Institutes of Health. 
The CBA/N-nu/nu  congenic strain, which carries both the xid and the nu genes, was prepared 
by a breeding strategy identical to that described for N:NIH(S)II-nu/nu  mice (17). 
Anttgens.  Trinitrophenylated B. abortus (TNP-BA) was prepared as previously described and 
used  at  a  10  -s  dilution  of the  stock antigen  (11).  LPS of Escherichia ¢oli 0111:B4  (Difco 
Laboratories, Detroit, MI) was used at a concentration of 50/xg/ml. 
Cell  Culture.  A  microadaptation  (11)  of the Mishell-Dutton  technique  (18)  was used  to 
evaluate in vitro antibody production to TNP-BA. Spleen cells (106) were cultured in 0.2 ml of 
Mishell-Dutton  medium  containing  10%  fetal  calf serum  (FCS)  medium,  in  flat-bottomed 
microtiter wells  (Costar, Data Packaging, Cambridge, MA) and maintained  in a humidified 
environment of 5% COu and 95% air. Cells were harvested from individual microwells after 4 
d  of culture, and the number of direct plaque-forming cells  (PFC) was assayed with a  Slide 
modification of the Jerne hemolytic plaque assay.  Target erythrocytes were TNP coupled by 
the method of Rittenberg and Pratt (19). For evaluation of the proliferative response to LPS, 
5  ×  105 cells/well  were cultured  under similar conditions, and  [SH]thymidine (6 Ci/mM,  1 
/tCi/microwell)  was added at 48 h of culture. Cells were harvested at 64 h with a  MASH II 
harvester (Microbiological Associates,  Walkersville, MD), and incorporation of [aH]thymidine 
was measured with a liquid scintillation spectrometer (Searle Radiographics, Des Plaines, IL). 
Enumeration of Surface Immunogtobulin (sIg) + Cells.  Spleen cells were washed and resuspended 
in complete media containing'0.2% azide and stained with a fluorescein conjugate of affinity- 
purified rabbit anti-mouse IgM, or with a fluorescein conjugate of 10-4.22, a hybridoma anti 
IgD (20), and analyzed on a fluorescence-activated cell sorter (FACS II: B-D FACS Systems, 
Becton,  Dickinson  &  Co.,  Sunnyvale,  CA)  as  previously  described  (21,  22).  The  median 
fluorescence intensity is that channel above and below which lie 50% of the positively stained 
cells. 
Inhibition  Radioiramunoassay  to  Quantitate Serum Ig  Concentration.  Flexible,  round-bottomed 
polyvinylchloride microtiter plates (Dynatech Laboratories Inc., Dynatech Corp., Alexandria, 
VA)  were coated with  purified  myeloma proteins  from the  tumors FLOPC-21  (IgG3,g) or 
Y5606  (IgG3,r),  TEPC-15  (IgA,r),  MOPC-21  (IgG1,K) UPC-10  (IgGXa,~),  MOPC-195S 
(IgG2h,K), or TEPC-183 (IgM,g) at a concentration of 10 ~g/ml in phosphate-buffered saline 
(PBS),  pH  7.4 for 1-2 h  (5.0/xl/well).  Purified FLOPC21, Y5606,  TEPC15, and TEPC  183 
myeloma proteins were purchased from Litton Bionetics, Kensington, MD, and  MOPC-21, 
UPC-10, and MOPC-195S myeloma proteins were purified by protein A-Sepharose affinity 
chromatography as previously described (23). Following the initial incubation, the wells were 
washed, and 100 #1 of PBS plus 1% bovine serum albumin (BSA) was added to each well for 1 
h to reduce subsequent nonspecific protein binding. 
The  inhibition  assay  for quantitation  of various  Ig classes  in  serum  was  performed  by 
incubating an aliquot of various dilutions of serum ranging from 1:40 to 1:2,400, or an a~[quot 
of various concentrations of purified myeloma protein ranging from 0.008 #g/ml to 10/~g/ml 
a  3  3  3  with an equal aliquot of [ H]goat anti-lgA, [ H]goat anti-Ig,  G1, [ H]goat anti-IgG2a, [ H]goat 
3  3  anti-IgG2b, [ H]goat anti-IgM, or [ H]rabbit anti-IgG3. The diluent used was PBS +  1% BSA 
+  0.1% sodium azide +  0.005  M  disodium ethylene diamine tetraacetate.  The labeled anti- 
isotype reagent was incubated with the serum dilution or purified Ig for 30 min before transfer 
to  the  myeloma protein-coated  wells.  After a  2-3  h  incubation  in  the  wells,  the  solution 
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the amount of [3H]labeled  anti-isotype reagent bound to each Ig-coated well assayed with the 
use of a liquid scintillation spectrometer. Standard curves of the inhibition of [aH]anti-isotype 
binding by various concentrations of purified myeloma proteins were constructed through a 
log/log plot. The standard curves were used to determine the concentration of various isotypes 
in the various serum samples tested.  Six individual  serum samples within  each group were 
tested in duplicate to quantitate  the amount of Ig in serum from 6-wk-old CBA/Ca na/nu, 
CBA/Ca na/ + , CBA/N nu/nu, and CBA/N na/+ mice. 
Cell sIg Radiolabeling, Immunoprecipitation, and Analysis.  Methods for cell  membrane radioio- 
dination and immunoprecipitation of sIg have been described in detail elsewhere (24). Briefly, 
5 ×  l0  s to 10 x  106 spleen cells, depleted oferythrocytes, were radioiodinated by lactoperoxidase- 
catalysis and lysed in Nonidet P-40 detergent. After ccntrifugation, the clarified lysates were 
incubated for 1-2 h with a  mixture of affinity-purified rabbit  anti-~, #, and 8 chain-specific 
antibodies, followed by precipitation of the immune complexes with  100-150 #1 of 10°7o fixed 
protein A-beating Staphylococcus aureus (Staph A) bacteria. The precipitates were washed and 
solubilized with sodium dodecyl sulfate (SDS)  buffer. 
Samples were reduced in 5% fl-mercaptoethanol and analyzed on vertical polyacrylamide 
gel slabs in a discontinuous SDS polyacrylamide gel electrophoresis (SDS-PAGE) system (25). 
The gel  slabs were processed for fluorography using the diphenyloxazole/dimethylsulfoxide 
system (26) and Kodak X-Omat R film (Eastman Kodak Co., Rochester, NY) was exposed to 
the gel under linear conditions in the presence of DuPont lightning plus intensifying screens 
(DuPont Instruments, Wilmington, DE), for 12-24 hr.  Peak integrations to obtain #:8 ratios 
were performed on the fluorograms using a Zeineh soft-laser scanning densitometer. 
Histological preparation.  Tissue samples of CBA/Ca-+/nu and nu/nu and of CBA/N-+/na 
and nu/nu mice were fixed in B-5 and processed by paraffin sectioning for hematoxylin and 
eosin staining. Sections were made of inguinal, axillary, and mesenteric lymph nodes, and of 
spleen. 
Results 
The Failure of TNP-BA and of LPS to Induce Responses by B  Cells from CBA/N-nu/nu 
Mice.  Spleen  cells  from mice with  the nu/nu- or xid-determined  defect  respond  to 
TNP-BA in vitro with the production of direct PFC of a  magnitude comparable to 
that obtained with cells from their respective normal litter mates. Quite unexpectedly, 
however,  the  in  vitro  anti-TNP-BA  response  of cells  obtained  from  6-8  wk-old 
CBA/N-nu/nu  mice was  markedly  reduced.  In the  majority  of cultures  established 
in microwells, the anti-TNP response to TNP-BA was undeteetable  (Table I). Even 
when  l0  T cells were cultured  in larger 35-mm wells,  the responses of CBA/N-nu/nu 
spleen cells was still  drastically reduced  as compared with the response of CBA/N- 
nu/nu cells. Anti-TNP-BA responses were evaluated using different amounts of antigen 
and  assayed  for anti-TNP-responses  on  days  3-4  of culture,  with  the  same  results 
(data not shown). 
The in vitro proliferative response of such cells to LPS was also severely impaired 
(Table II). Marked diminution of the proliferative response was seen using all doses 
of LPS tested (Table III). In most experiments the proliferative responses of CBA/N- 
nu/nu  spleen  cells  was  <10%  that  of CBA/N-+/nu  cells,  whereas  the  responses  of 
CBA/Ca nu/nu spleen cells were no different than  that of the CBA/Ca-+/nu spleen 
cells. 
In  Vivo Responses of CBA/N and CBA/Ca (nu/nu) Mice to Intravenous Injection of TNP- 
BA.  To examine the response of CBA/N-nu/nu mice and -+/nu litter-mate controls 
to in vivo immunization with a  type 1 antigen, TNP-BA was injected intravenously, 
and anti-TNP-PFCI responses were evaluated.  Both direct and facilitated anti-TNP- 
PFC responses of CBA/N-nu/nu mice were significantly diminished as compared with MOND  ET  AL.  927 
TABLE  I 
Anti TNP-BA PFG Response of Cells Obtained  from CBA/N-nu/ nu and CBA/Ca-nu/ nu Mice and from 
Their  + / nu Normal Litter Mates* 
Experiment  Cells/well 
Anti TNP-PFC/10  ° cultured cells 
CBA/Ca-+ / nu  CBA/Ca-nu/ nu  CBA/N-+  / nu  CBA/N-nu/ nu 
1  106  326  638  494  0 
2  10  °  444  278  147  0 
3  106  ND:[:  880  416  0 
4  10  °  ND  510  405  0 
5  107  261  300  120  4 
6  10  v  ND  ND  100  18 
* 10  n spleen cells taken from CBA/N or CBA/Ca-nu/nu  and +/nu mice were cultured together with TNP- 
BA  in  modified  Misheli-Dutton  medium.  4  d  later cells  were  harvested  and  anti-TNP  PFC  were 
determined. Results shown represent PFC/10  s cultured cells after background plaques were subtracted. 
In experiments 5  and 6,  10  q spleen cells were cultured in Linbro plates of 35 mm  (Linbro Scientific 
Hamden, CT). In all experiments, pools of spleen cells from two CBA/N-+/nu, CBA/Ca-+/nu, or CBA/ 
Ca-nu/nu mice were used.  CBA/N-nu/nu  cells  from individual animals were cultured separately. The 
number of CBA/N-nu/nu mice used in experiments  1-6 were 3, 4, 5, 3, 2, and 3, respectively. Results 
represent geometric mean of triplicate wells using spleen cell pools except for CBA/N-nu/nu mice which 
were cultured as individual spleens. 
:~ Not done. 
TABLE II 
In Vitro Proliferative Response of Cells Obtained  fiom CBA/N-nu/nu and CBd/Ca-nu/nu or  from  Their 
+/nu Normal Litter Mates to LPS 
Experiment  CBA/Ca-+ / nu  CBA/Ca-nu/ nu  CBA/N-+  / nu  CBA/N-nu/ nu 
A cpm ± SE  A cpm ± SE 
1  32,492  48,890  35,540  2,886 ±  1421 
2  28,654  25,151  25,661  1,091 ±  326 
3  ND*  37,240  36,242  656 :l: 122 
4  ND  ND  63,920  2,608 ±  509 
2.5 X 105 spleen cells were cultured with 50 #g/ml of E. coil  LPS in modified Mishell Dutton medium. At 
48 h of culture 1 #Ci of [aH]thymidine was added, and 18 h later cells were harvested using a MASH II 
cell harvester and counted in a liquid scintillation counter. In all experiments pools of spleen cells from 
two CBA/Ca-+/nu or nu/nu and CBA/N-+/nu were used. CBA/N-nu/nu cells from individual mice were 
cultured  separately.  The  number of CBA/N-nu/nu  mice  used  in  experiments  1-4  were  2,  4,  5,  5, 
respectively, and results are expressed as the arithmetic mean of the individual responses (±SE). 
* Not done. 
CBA/N-+/nu  mice (Fig.  1). Whereas  the direct anti-TNP-PFC  response was reduced 
by  80%,  the  indirect  PFC  response  was  >90%  reduced.  In  contrast  to  this,  the 
magnitude  of the direct anti-TNP-PFC  response of CBA/Ca-nu/nu  mice was equiva- 
lent to that of +/nu mice 4  d  after immunization.  The  facilitated anti-TNP  response 
of CBA/Ca-nu/nu  mice was comparable  to that  of +/nu  mice early in  the response, 
but  did  not  show  the  progressive  increase  in  anti-TNP  plaques  with  time  after 
immunization  as did the control CBA/Ca-+/nu  mice. 
Serum  Immunoglobulin  Levels  of CBA/N-nu/nu  and  CBA/Ca-nu/nu  Mice and  of Their 
Normal Litter Mates.  Although  it appeared  that CBA/N-nu/nu  mice were profoundly 
defective in their response to the type  1 antigen TNP-BA  and the B  cell mitogen  LPS, 
it was conceivable that various other environmental  antigens might  be more  effective 
in stimulating  the immune  system in such mice. To evaluate this possibility, serum Ig TABLE  III 
In Vitro Proliferative Response of CBA/ N-nu/ nu and CBA/N-nu/ +  Spleen 
Cells to Various Concentrations of LPS* 
Mitogen added  CBA/N-nu/ nu  CBA/N-nu/  + 
cpm ± SE 
None  776 +  443  2,687  :t:  777 
LPS 50 #g/ml  3,099  ±  317  63,812  ±  3.286 
5/tg/ml  761  :t: 47  31,630  ±  3,494 
0.5 #g/ml  99l  ±  388  12,326 ±  2,166 
* 5 X  105 cells obtained from CBA/N-nu/+ or nu/nu mice were incubated with 
various concentrations of LPS.  1/~Ci of [3H]thymidine was added at 48 h of 
culture, and  18 h  later cells were harvested on the MASH II cell  harvester 
and counted in a liquid scintillation counter. 
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A CBA~N  +lnu 
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4  6  8 
DAYS AFTER IMMUNIZATION 
Fxc.  1.  CBA/N-+/nu or nu/nu and CBA/Ca-+/nu or nu/nu were immunized intravenously with 
0.1  ml of TNP-BA and both direct and facilitated  anti-TNP PFC were determined 4, 6, and 8 d 
later. Each point represents the average of the response of three individual mice per group and the 
error bars encompass ±1 SE of the mean. 
levels  of CBA/N  and  CBA/Ca-nu/nu  and  +/nu  mice  were  determined  using  an 
inhibition radioimmunoassay (Table IV). As previously described (27, 28), the serum 
IgM and IgG3 concentrations of euthymie CBA/N mice are significantly reduced as 
compared with the serum IgM and IgG3 concentrations of CBA/Ca mice, whereas 
the concentration of the other isotypes were comparable in normal and xid mice. In 
marked contrast to this, the concentrations of all classes of serum Ig were reduced in MOND  ET  AL.  929 
TABLE IV 
Serum Ig Levels of CBA/N-nu/nu and CBA/Ca-nu/nu  Mice and of Their Normal +/nu Litter Mates 
Serum Immunogloblin Concentration 
(#g/ml) * 
IgM  IgG  IgG1  IgG2b  IgG~.  IgA 
CBA/N-+/nu  (n =  6)  257 :l: 24  24:1:7  250 ±  37  1,094 ±  110  796:1:76  65 ±  10 
CBA/N-nu/nu  (n =  6)  52 ±  15  0.01  16 ±  9  8 ±  4  16 :l: 7  1.3 :t: .7 
CBA/Ca-+/nu  (n =  6)  1,185  :l: 41  215 ±  34  484 :l: 95  850 ±  185  724 ±  45  61 ±  7 
CBA/Ca-nu/nu  (n =  6)  1,208:1:64  252 ±  62  128:1:39  373 ±  77  807 ±  95  31 ±  5 
* Serum Ig levels were quantitated through the use of an inhibition radioimmunoassay. Various dilutions 
of each serum were tested for their ability to inhibit the binding of [SH]-labeled  anti-isotype reagents to 
myeloma-coated microtiter wells. The amount of inhibitory Ig of each class was quantitated through the 
use of standard curves established from the appropriate myeloma inhibitors. Results are expressed as 
mean #g/ml concentration of six individual sera ±SE. 
TABLE  V 
FACS Analysis of slgM  + and of sIgD + Spleen Cells of CBA/N-nu/nu and CBA/Ca-nu/nu  Mice and of 
Their Normal +/nu Litter Mates* 
Percent sIgM  ÷  Median  Median 
fluorescence  Percent sIgD  +  fluorescence  Donor cells:~  Age  cells  cells 
intensity  intensity 
wk 
CBA/Ca-nu/nu  4  56.3  49  58.7  46 
nu/+  48.1  39  50.7  59 
CBA/N-nu/ nu  46.0  100  31.6  21 
nu/nu  4  44.5  101  27.6  20 
nu/+  42.1  98  41.6  43 
CBA/Ca-nu/nu  6  56.3  49  62.8  61 
nu/+  36.8  36  33.9  67 
CBA/N-nu/nu  44.0  85  31.7  26 
nu/nu  6  49.7  95  32.2  26 
nu/+  35.0  76  34.9  87 
* 10  s cells obtained from various donor mice were washed and prepared for analysis on the FACS after 
staining with  FITC-10-4.22  (anti-8)  or  FITC  anti-#.  The  percent  of sIgD  +  and  sIgM  +  cells  were 
enumerated, and the median fluorescence intensity of the positive cells was determined. 
Each group consists of a pool of two mice. 
CBA/N-nu/nu  mice as compared  with that  seen in CBA/N-+/nu or in CBA/Ca-nu/ 
nu mice. Indeed, the concentration  of IgM, which at 52 #g/ml  was the most abundant 
isotype in CBA/N-nu/nu serum, was only 20% of the CBA/N  IgM serum concentration 
and  ~5%  of CBA/Ca  IgM  serum  concentration.  All other  Ig classes  were  found  at 
concentrations  of 16 #g/ml  or less in CBA/N-nu/nu  serum. 
FACS Analysis of sIg + B Lymphocytes in CBA/ N-nu/ nu Mice and SDS-PAGE Quantitation 
of the Expression of sIgD and sIgM.  To  evaluate  whether  the diminished  responses of 
CBA/N-nu/nu  mice  was  a  reflection  of reduced  numbers  of B  lymphocytes  in such 
mice, spleen cells from CBA/N-nu/nu,  CBA/Ca-nu/nu  mice,  and  of their +/nu litter 
mates  were  stained  with  fluorescein  conjugates  of anti-#  and  anti-8  antibodies  and 
analyzed  on the FACS  (Table V).  At both  4  and  6  wk of age,  the fraction of sIgM + 930  ROLE  OF THE  THYMUS  IN DEVELOPMENT  OF A  B LYMPHOCYTE  SUBSET 
cells in CBA/N-nu/nu mice was ~45%,  a  value comparable to that of CBA/N  mice. 
As described previously (29),  the median  fluorescence intensity of the IgM positive 
CBA/N  cells was  significantly higher  than  that  of CBA/Ca  B  cells,  reflecting an 
increased expression of sIgM on the B  cells of CBA/N  mice. CBA/N-nu/nu cells also 
displayed this  increased  expression of sIgM  on  their  B  cells. Despite the  relatively 
normal fraction of sIgM  + B lymphoeytes in CBA/N-nu/nu mice, the absolute number 
of B  lymphoeytes in the spleens of CBA/N-nu/nu mice was three- to fourfold lower 
TABLE VI 
Analysis of the IgD/ IgM Ratio on Cells of the CBA/N nu/nu Mice Using 
SDS-  PAGE 
Cells used*  Age  sIgD/sIgM~ 
wk 
CBA/N-nu/nu  5  0.38 
nu/ +  1.14 
CBA/Ca-nu/nu  5  1.80 
nu/ +  1.94 
* Spleen cells from two or three mice of the indicated strains were radioiodi- 
hated, immunoprecipitated,  and subjected  to SDS-PAGE analysis as de- 
scribed in Materials and Methods. 
:~ The  area under  sIgD  and  sIgM  peaks  was  determined  as  described  in 
Materials and Methods, and the ratio between the two calculated. 
FIo.  2.  Lymph nodes from adult (8-12-wk) mice; initial magnification  × 40. A, CBA/Ca-+/nu; 
B, CBA/N-+/nu; C, CBA/(2a-nu/nu; D, C,  BA/N-nu/nu. MOND  ET  AL.  931 
than that of CBA/N-nu/nu mice, because the total number of  spleen cells was reduced 
by this fraction (data not shown). 
There was a significant excess in the percentage of cells that were sIgM  + over sIgD  + 
in the spleens of 4- and 6-wk-old CBA/N-nu/nu mice, which was not observed in 
CBA/Ca mice. This was consistent with approximately one third of the cells from 
CBA/N-nu/nu mice of both 4 and 6 wk of age, being sIgM  + sIgD-. Furthermore, the 
median fluorescence intensity of IgD on sIgD  + cells of CBA/N-nu/nu mice was two- 
to threefold less than that of cells obtained from CBA/N-+/nu  mice, and there was 
no increase in the intensity of staining with anti IgD between 4 and 6 wk of age of the 
CBA/N-nu/nu mouse despite the observed twofold increase in median  fluorescence 
intensity of sIgD  ÷ cells from 6-wk-old +/nu litter mates. 
To further quantitate the expression of sIgD and sIgM on cells from CBA/N-nu/nu 
mice, cells were radiolabeled by lactoperoxidase catalyzed iodination  followed by 
SDS-PAGE (Table VI). It is apparent that the IgD/IgM ratio on the cells obtained 
from CBA/N-+/nu  mice is substantially less  than that  of CBA/Ca-+/nu  or nu/nu 
cells, as previously reported (30). However, the IgD/IgM ratio from CBA/N-nu/nu 
cells is strikingly lower than that of the +/nu litter mates. 
Histology of CBA/N-nu/nu Peripheral Lymph Node.  Examination of sections of pe- 
ripheral lymph nodes of CBA/N-nu/nu mice revealed the virtual absence of lympho- 
cytes; the only cells identifiable in these sections were stromal cells (Fig. 2 D). Sections 
of lymph nodes from CBA/Ca-nu/nu mice showed the presence of lymphocytes only 
in the far cortex; primary follicles without germinal centers were scattered throughout 
this  area.  The  paracortex  and  medulla  were  devoid  of lymphocytes  (Fig.  2 C). 
CBA/N-+/nu lymph nodes (Fig. 2 B) were similar to those of CBA/Ca-+/nu mice in 
that they exhibited well-developed germinal centers, but appeared to have decreased 
numbers of small mantle layer lymphocytes surrounding the germinal centers, and a 
normal distribution of lymphoeytes. These unusual histologic findings resemble those 
previously reported for NIH(s)II-nu/nu mice (17)  (which expresses the xid defect), as 
do the abnormalities observed in the spleens of CBA/N-nu/nu mice. 
Discussion 
There is little evidence from the murine system that the thymus plays a role in the 
development ofB lymphocytes, because by all measures the function ofB lymphocytes 
from nu/nu mice is normal. However, because many of the functions tested in mt/nu 
mice are presumably the result of the activation of Lyb-5  + cells, it was of interest to 
study the functional capacity of B lymphocytes of nu/nu mice that expressed the xid 
defect, and thus lacked Lyb-5  + cells.  If the thymus played no role in B lymphocyte 
development, one would expect that the functional properties of the B lymphocytes 
from such mice to be similar to those of CBA/N  +/nu  B  lymphocytes. However, 
when tested in vitro, the spleen cells of CBA/N-nu/nu mice showed markedly reduced 
responsiveness to LPS and to TNP-BA when compared to the spleen cells of CBA/N- 
+/nu or CBA/Ca-mt/nu mice. Similar findings were obtained in in vivo studies of the 
responsiveness of CBA/N-nu/nu mice to TNP-BA. 
In  addition  to  their  low  responsiveness  to  type  1 antigens, CBA/N-nu/nu mice 
showed a >80% diminution in the concentration of serum IgM and a >95% diminu- 
tion in the serum concentrations of each of the IgG classes and IgA when compared 
with  CBA/Ca-mt/nu mice.  Thus,  unlike  CBA/N-+/nu  mice  who  have  relatively 932  ROLE  OF THE THYMUS  IN DEVELOPMENT  OF A B  LYMPHOCYTE  SUBSET 
normal serum concentrations of IgG1, Igb2a, IgG2b, and IgA and lower levels of IgM 
and  IgG3, CBA/N-nu/nu mice have  reduced levels of all classes of serum  Ig. These 
concentrations are significantly lower than those seen in germ-free mice (31), suggest- 
ing that CBA/N-nu/nu mice fail to respond to environmental antigens. Despite these 
low serum  Ig levels, these mice have  a  mortality similar to  that  of CBA/Ca-nu/nu 
mice, under  laboratory conditions. The  abnormally low responses of CBA/N-nu/nu 
mice to TNP-BA  or  LPS  and  their inability to respond to environmental  antigens 
indicates that the B  lymphocytes of mice that express the xid defect do not function 
normally in the absence of a  thymic influence. 
Because  it  appears  that  the  thymus  plays an  important  role  in  influencing  the 
development of a  class of B  lymphocytes, it was of interest to determine whether this 
influenced  the  frequency  of  sIg  +  cells  or  their  maturational  status.  The  average 
number of lymphocytes in the spleens of CBA/N-nu/nu mice was 3  ×  107 to 4  ×  107, 
whereas  the number  of cells from  CBA/N-+/nu spleens was  9  ×  107  to  10  ×  107. 
The maturational status of B  lymphocytes from these mice was initially studied using 
radiodination,  immunoprecipitation  followed by  SDS-PAGE analysis. The  ratio of 
surface p  vs. 6 on the B  lymphocytes of CBA/N-nu/nu mice was considerably higher 
than  on  B  lymphocytes of CBA/N- +/nu  mice at 6  wk of age. The expression of B 
lymphocyte sIgM and sIgD was further studied using the FACS. No differences were 
noted  in  the  frequency  of sIgM  +  cells or  in  their median  fluorescence  intensity as 
compared  to  CBA/N-+/nu  cells. The  increase in  median  fluorescence intensity of 
sIgM  on  these  cells as  compared  with  either  normal  nu/nu or  normal  +/nu  mice 
reflects the immaturity of these cells and  is a  result of the xid defect  (29).  However 
CBA/N-nu/nu B  lymphocytes did not  resemble those of CBA/N-+/nu  mice in that 
the  frequency  of sIgM  +  sIgD-  cells  was  increased,  and  represented  a  significant 
proportion of B  lymphocytes of CBA/N-nu/nu at  both 4  and  6  wk of age.  Further- 
more, those CBA/N-nu/nu cells that were sIgD  + expressed significantly less sIgD that 
11 neonatal  "e'4~e~ 
2) CeA/N-nu/nu 
CBA]N 
FxG. 3.  Proposed scheme of B lymphocyte development. The population of immature Lyb-5- B 
cells contains  precursors that develop into mature Lyb-5  + B cells and others  that develop into 
mature Lyb-5- B cells. The former developmental  pathway is independent  of T  cell influence, 
whereas the latter is dependent on T cell or thymic regulation. Mature Lyb-5  + B cells are found in 
normal adult mice and in adult nu/nu mice of normal strains. Mature Lyb-5- B cells are found in 
normal adult mice and in mice with the xid defect (i.e., CBA/N mice). Immature Lyb-5- B cells are 
found in neonatal normal mice and in congenitally athymic xid mice (i.e., CBA/N-nu/nu mice). MOND ET AL.  933 
CBA/N-+/nu cells as reflected in their low median fluorescence intensity. Thus, the 
increased ratio of incorporated radioactivity in 8 versus # of CBA/N-nu/nu B lympho- 
cytes reflects both a decreased number of slgD  + cells and a reduced surface expression 
of slgD on these cells, as well as an increased expression of slgM. This phenotype is 
characteristic of the B lymphocytes of very immature normal or CBA/N mice (32- 
34). 
In the course of these experiments we found that CBA/N-nu/nu mice > 12 wk of age 
sometimes displayed greater responses to TNP BA and LPS than did mice 6-8 wk of 
age. Thus the profound B cell defect seen in animals expressing the nu and xid genes 
may be more of a delay in B cell maturation than a complete block. It is possible that 
the increase in responsiveness of older CBA/N-nu/nu mice may reflect the presence of 
increased numbers of T  cells in these mice as has been reported in older strains of 
nude mice  (35). Additionally,  it has been reported that  development of immature 
thymocytes can proceed in the absence of direct thymus influence (36)  and may be 
accelerated in the presence of T cell derived factors (37) as well as by LPS conditioned 
media  (38).  Alternatively,  there  may  be  other,  less  efficient  pathways  for  B  cell 
development that are influenced solely by macrophages or other cellular and humoral 
factors. 
The data presented here suggest that a thymic influence is critical for the normal 
development of mature  Lyb5- B  lymphocytes from  their precursors  and  that  the 
development of Lyb5  + B lymphocytes, present in CBA/N-nu/nu mice but not in CBA/ 
N-nu/nu  mice, is not dependent  (or is less dependent) on a  thymic influence. If this 
were the case, it would imply that mature Lyb-5- and Lyb-5  + B lymphocytes arise 
along independent paths of cell differentiation (Fig. 3). Another possibility might well 
be that the Lyb5- B lymphocytes of the CBA/N mouse are not equivalent to Lyb-5- 
B lymphocytes of normal adult mice, and it is only the former population of cells that 
require a thymic influence, whereas the latter population develops in a normal fashion 
in the absence of a thymus. 
Summary 
In an effort to evaluate the role of the thymus in influencing the development of 
Lyb-5- B lymphocytes, mice expressing both the xid and nu gene defects were studied. 
Mice expressing either of these defects respond to both trinitrophenylated BruceUus 
abortus and lipopolysaccharide; whereas mice with the combined defect show markedly 
suppressed responses. The other abnormalities included:  (a) >80 percent diminution 
of serum Ig levels; (b) significant increase in the number of slgM + slgD- B lympho- 
cytes;  (c)  reduced expression of IgD on slgD  + cells;  and  (d)  a  strikingly abnormal 
histology of their lymphoid tissue.  Because nu/nu  mice that  do not express the xid 
defect appear relatively normal, it would suggest that the development of Lyb-5- B 
lymphocytes require a  thymic influence for normal maturation, whereas, Lyb-5  + B 
lymphocytes are relatively independent of such influences. 
Received  for publication 30 October 1981. 
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